| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7462210
[patent_doc_number] => 20040166109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'FEBP1 protein vector host cells and method for making FEBP1 protein'
[patent_app_type] => new
[patent_app_number] => 10/726721
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8788
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726721 | FEBP1 protein vector host cells and method for making FEBP1 protein | Dec 2, 2003 | Issued |
Array
(
[id] => 1027548
[patent_doc_number] => 06881409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-19
[patent_title] => 'Compositions and methods for promoting nerve regeneration'
[patent_app_type] => utility
[patent_app_number] => 10/656701
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 10493
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656701 | Compositions and methods for promoting nerve regeneration | Sep 3, 2003 | Issued |
Array
(
[id] => 6769458
[patent_doc_number] => 20030215398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Method for administering brain-derived neurotrophic factor to the brain'
[patent_app_type] => new
[patent_app_number] => 10/464398
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4487
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215398.pdf
[firstpage_image] =>[orig_patent_app_number] => 10464398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/464398 | Method for administering brain-derived neurotrophic factor to the brain | Jun 17, 2003 | Abandoned |
Array
(
[id] => 7286944
[patent_doc_number] => 20040146946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Olfactory neuron cultures and method of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/422006
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6115
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422006 | Olfactory neuron cultures and method of making and using the same | Apr 22, 2003 | Abandoned |
Array
(
[id] => 1161933
[patent_doc_number] => 06759188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Method for producing interleukin 1 receptor antagonists, a therapeutic activity protein, from body fluids'
[patent_app_type] => B2
[patent_app_number] => 10/331583
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6666
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331583 | Method for producing interleukin 1 receptor antagonists, a therapeutic activity protein, from body fluids | Dec 30, 2002 | Issued |
| 90/006459 | ISOLATION PROPAGATION AND DIRECTED DIFFERENTIATION OF STEM CELLS FROM EMBRYONIC AND ADULT CENTRAL NERVOUS SYSTEM OF MAMMALS | Nov 20, 2002 | Pending |
Array
(
[id] => 7607730
[patent_doc_number] => 07097984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Method of utilizing neurotrophins to manipulate reproductive capacity'
[patent_app_type] => utility
[patent_app_number] => 10/209779
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10467
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/097/07097984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209779
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209779 | Method of utilizing neurotrophins to manipulate reproductive capacity | Jul 30, 2002 | Issued |
Array
(
[id] => 6846990
[patent_doc_number] => 20030166157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Recombinant DNA vectors for expression of somatotropins'
[patent_app_type] => new
[patent_app_number] => 10/173082
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1257
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10173082
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/173082 | Recombinant DNA vectors for expression of somatotropins | Jun 16, 2002 | Issued |
Array
(
[id] => 6715953
[patent_doc_number] => 20030027301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Novel human transporter proteins and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/173123
[patent_app_country] => US
[patent_app_date] => 2002-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9907
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10173123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/173123 | Novel human transporter proteins and polynucleotides encoding the same | Jun 13, 2002 | Abandoned |
Array
(
[id] => 1062672
[patent_doc_number] => 06849416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-01
[patent_title] => 'Monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 10/170272
[patent_app_country] => US
[patent_app_date] => 2002-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 34433
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849416.pdf
[firstpage_image] =>[orig_patent_app_number] => 10170272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/170272 | Monoclonal antibody | Jun 10, 2002 | Issued |
Array
(
[id] => 6654066
[patent_doc_number] => 20030077252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming'
[patent_app_type] => new
[patent_app_number] => 10/162889
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 25767
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10162889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/162889 | Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming | Jun 5, 2002 | Abandoned |
Array
(
[id] => 985538
[patent_doc_number] => 06924266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'NTP-peptides and method for removal of tumors'
[patent_app_type] => utility
[patent_app_number] => 10/153334
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20134
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153334 | NTP-peptides and method for removal of tumors | May 23, 2002 | Issued |
| 10/069819 | Screen for axon viability | May 20, 2002 | Abandoned |
| 10/019365 | Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins | May 16, 2002 | Abandoned |
Array
(
[id] => 6769944
[patent_doc_number] => 20030215884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Method of regenerating neurons'
[patent_app_type] => new
[patent_app_number] => 10/145541
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22328
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10145541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/145541 | Method of regenerating neurons | May 13, 2002 | Abandoned |
Array
(
[id] => 6668857
[patent_doc_number] => 20030113841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => '8105, a novel human sugar transporter family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/144624
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 47770
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144624 | 8105, a novel human sugar transporter family member and uses thereof | May 12, 2002 | Abandoned |
Array
(
[id] => 6664077
[patent_doc_number] => 20030203403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40'
[patent_app_type] => new
[patent_app_number] => 10/135592
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8621
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135592 | Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40 | Apr 29, 2002 | Issued |
Array
(
[id] => 6674253
[patent_doc_number] => 20030059856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Methods of screening for agonists and agonists of the interaction between the AXOR8 and AXOR52 receptors and ligands thereof'
[patent_app_type] => new
[patent_app_number] => 10/132812
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 16437
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059856.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132812 | Methods of screening for agonists and agonists of the interaction between the AXOR8 and AXOR52 receptors and ligands thereof | Apr 24, 2002 | Abandoned |
Array
(
[id] => 6405948
[patent_doc_number] => 20020182646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders'
[patent_app_type] => new
[patent_app_number] => 10/133785
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15011
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133785 | Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders | Apr 24, 2002 | Abandoned |
Array
(
[id] => 1065425
[patent_doc_number] => 06846641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-25
[patent_title] => 'In vitro ischemia model'
[patent_app_type] => utility
[patent_app_number] => 10/131731
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 13863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10131731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/131731 | In vitro ischemia model | Apr 22, 2002 | Issued |